Search

everythinglearnresearchcommunity

for

Search:↓

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Hair loss treatment caused more hair loss in a man.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Minoxidil can cause a skin reaction called ALEP.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.